Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

This phase IIa trial studies the side effects of abemaciclib monotherapy in treating patients age 70 years and older with hormone receptor positive, HER2 negative breast cancer that has spread to other places in the body.

Trial Details

NCT ID
NCT04305834
Phase
PHASE2
Sponsor
City of Hope Medical Center
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Abemaciclib
  • Questionnaire Administration
Locations (sample)
  • Duarte, California, United States|34.13945,-117.97729
  • Irvine, California, United States|33.66946,-117.82311
  • Long Beach, California, United States|33.76696,-118.18923
  • South Pasadena, California, United States|34.11612,-118.15035
  • Boston, Massachusetts, United States|42.35843,-71.05977

Key Eligibility Criteria

  • Documented informed consent of the participant
  • Age \>= 70 years
  • Life expectancy \> 6 months
  • Ability to read and understand English or Spanish

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →